Maximizing the stability of oxygen delivered via nasal cannula.
about
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.Impact of oxygen concentration on time to resolution of spontaneous pneumothorax in term infants: a population based cohort study.The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.Oxygen administration in infants.Reliability of a Noninvasive Measure of V./Q. Mismatch for Bronchopulmonary DysplasiaThe N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.A model for oxygen conservation associated with titration during pediatric oxygen therapyPercutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications.High flow nasal cannula therapy as respiratory support in the preterm infant.Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia.In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia.A randomised crossover study of low-flow air or oxygen via nasal cannulae to prevent desaturation in preterm infants.Effect of cumulative oxygen exposure on respiratory symptoms during infancy among VLBW infants without bronchopulmonary dysplasia.Quality improvement to reduce chronic lung disease rates in very-low birth weight infants: high compliance with a respiratory care bundle in a small NICU.Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: Which are the Real Benefits of the Percutaneous Approach?Children's Oxygen Administration Strategies Trial (COAST): A randomised controlled trial of high flow versus oxygen versus control in African children with severe pneumonia.Infants born at <29 weeks: pulmonary outcomes from a hybrid perinatal system.Altitude, oxygen and the definition of bronchopulmonary dysplasia
P2860
Q30301367-0B131225-DC82-4832-B2F0-03E493C24168Q30416493-E49DC54F-6610-4892-8CB4-D5E6E2DF77A2Q34088920-4BC453C1-10A6-43C1-8243-6E1919F4FC2CQ34538793-D1362765-E586-48FC-9946-260740EF5851Q35070985-83C64C4B-849C-4FD8-BA2C-93E3A0D9AE70Q35565151-4D3A22A1-24D2-4B28-BCDF-AF4EFD88CB77Q36036623-1B6B9E0E-EA9C-4DFD-A5DB-C9CD80019CC0Q36289490-043B4794-A280-445A-98BC-FA6E81C5679CQ36714131-A6849DB9-55CB-46DE-8B85-89B139710BDAQ37508937-68DABC83-5A1A-41A3-90E7-4232BE7C7D6CQ40561597-7E28F79B-18DE-4048-9170-604A3F2D890FQ42347295-35229E02-ECF5-4DC2-9D1F-92DCC907FC5BQ43701957-295FC1D9-BA91-40C5-9166-FAAC02745478Q43912618-F2FA61F8-0BCF-4635-8045-D224051012C3Q47174061-CE76513B-3F1E-4BCC-A6BB-B7E6A4DB6285Q47177305-079E861C-1F48-4BD1-8BFB-CAA7B05B203FQ47643212-B33FD94F-9EAF-411E-B873-E9A6119E36BCQ50762884-BFC460DD-F6B8-433E-8CD6-67E02E1EB508Q57098283-5A991D40-DC1A-4BDC-8550-323446F93ADD
P2860
Maximizing the stability of oxygen delivered via nasal cannula.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Maximizing the stability of oxygen delivered via nasal cannula.
@en
Maximizing the stability of oxygen delivered via nasal cannula.
@nl
type
label
Maximizing the stability of oxygen delivered via nasal cannula.
@en
Maximizing the stability of oxygen delivered via nasal cannula.
@nl
prefLabel
Maximizing the stability of oxygen delivered via nasal cannula.
@en
Maximizing the stability of oxygen delivered via nasal cannula.
@nl
P1433
P1476
Maximizing the stability of oxygen delivered via nasal cannula.
@en
P2093
P304
P356
10.1001/ARCHPEDI.1994.02170030064015
P407
P577
1994-03-01T00:00:00Z